This is a limited company view. Sign up for a Free Trial to see everything.

Vaxess offers a technology that uses a silk-derived protein to stabilize vaccines so they can be stored and shipped without refrigeration.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Boston

Founded

2011

Employees

18

Stage

Series A

Total funding

$4M

Last funding

5 years ago

Acquisitions

0

Growth score

24

Mindshare score

12

Scoring

Deals

$3.8M Series A

Norwich Ventures

May 23, 2013

Undisclosed Amount Seed

MassChallenge

Jan 1, 2012

Employee Growth

Use Vaxess Technologies's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Vaxess Technologies's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Similar Companies

Kiromic

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.
Pre-Series A|17 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes